App-Quantinova.ai

Ten, 20, and 30-Year Outcomes of Patients After Fontan Operation

Eriko Shimada - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

N/A

Underuse and Underdose of Oral Anticoagulants for Patients With Atrial Fibrillation in Japan: From the Fushimi Af Registry

Hisashi Ogawa - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

rivaroxaban

Long-term Results of CarboMedics Mechanical Heart Valves: A Single Institutional Follow-up of 784 Prosthetic Valves Used for Both Primary and Re-operations for Recent 22 Years

Yasuhisa Oishi - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Quantified Coronary Frequency Domain Optical Coherence Tomography Signal Analysis for the Evaluation of Erythrocyte-Rich Thrombus: ex-vivo Validation Study

Masato Watanabe - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Cangrelor Decreases Ischemia Driven Revascularization in Patients Undergoing Percutaneous Coronary Intervention: Evidence From a Meta-analysis of Randomized Trials

Partha Sardar - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Streptase

Short-term Rapid Atrial Pacing Promotes Gene Expression of Prothrombotic Molecules in the Liver - Cardio-hepatic Interaction in Atrial Fibrillation

Takeshi Kato - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Thrombate III

Serum Alkaline Phosphatase is a Predictor of Mortality, Myocardial Infarction, or Stent Thrombosis after Implantation of Coronary Drug-Eluting Stent

Do-Yoon Kang - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Alkaline phosphatase

Silencing miR-145 Prevents Potentiating Effects of Human Electronegative Low-Density Lipoprotein on Platelet Activation

Fang-Yu Chen - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Outcomes of Concomitant Mitral Valve Repair Compared to Replacement in Patients Undergoing Aortic Valve Surgery: A Meta-analysis of Observational Studies

Venkata Mahesh Alla - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

HIF-1?/HuR Pathway Regulates the Increased Expression of PAI-1 Induced by Sphingosine 1-phosphate in HepG2 Cells Rendered Hypoxic: A Novel Linkage between Thrombosis and Hypoxia

Soichiro Iwaki - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Left Atrial Appendage Wall Velocity Obtained by Transthoracic Echocardiography May Be a Feasible Parameter to Detect High Risk Patients for Stroke Despite Low CHA2DS2-VASc Score

Tetsu Watanabe - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Neointimal Coverage of Everolimus-Eluting Stent Compared to Sirolimus-Eluting Stent: Optical Coherence Tomography Subanalysis from the RESET Trial

Takashi Kubo - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

In Vivo Monitoring of Atherosclerotic Evolution and Detection of Vulnerable Plaque in a Rabbit Model by 18F-FDG PET/CT

Xuecheng Zhao - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Atorvastatin

Long-Term Results of Cell-Free Biodegradable Scaffolds for In Situ Tissue-Engineering Pulmonary Artery in a Canine Model

Shojiro Matsuda - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Metabolic Syndrome and Postoperative Outcomes After Heart Valve Surgery

Giovanni Melina - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Thrombus Development Processes are Dependent on Endothelial Injuries: Examined by in vivo Molecular Imaging

Satoshi Nishimura - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Pulmonary Complications in Right Sided Endocarditis

fernando U Kay - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Diagnosing Heparin Induced Thrombocytopenia Post Cardiac Surgery

Cardiac Sciences Program - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Resistance of Thrombus to Fibrinolysis in Patients With Chronic Thromboembolic Pulmonary Hypertension -Possible Involvement of Thrombin-Activated Fibrinolysis Inhibitor (TAFI)-

Yoshihiro Fukumoto - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Alprostadil

Adjusted Risk Survival Benefit Following Angiographic Complete Percutaneous Revascularization in the Era of Drug-Eluting Stents

Sa`ar Minha - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts